| Lipids Management |
1 |
1 |
| PCSK9 |
0 |
0.99 |
| Cardiovascular Risk Management |
0 |
0.28 |
| Biologic Therapy |
0 |
0.24 |
| Monoclonal Antibody |
0 |
0.24 |
| Statins |
0 |
0.24 |
| LDL Cholesterol |
0 |
0.16 |
| Cardiovascular disease |
0 |
0.12 |
| Revenue and Practice Management |
0 |
0.1 |
| Adherence |
0 |
0.06 |
| Clinical Guidelines |
0 |
0.06 |
| Europe |
0 |
0.06 |
| Healthcare and Medical Technology |
0 |
0.06 |
| Hospital |
0 |
0.06 |
| Insurance |
0 |
0.06 |
| Lipoproteins |
0 |
0.06 |
| Medical Innovations |
0 |
0.06 |
| New York |
0 |
0.06 |
| Travel Medicine |
0 |
0.06 |
| Weight Loss |
0 |
0.06 |
| Weight Management |
0 |
0.06 |